Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,060,565
  • Shares Outstanding, K 45,923
  • Annual Sales, $ 1,147 M
  • Annual Income, $ -20,370 K
  • 60-Month Beta 0.83
  • Price/Sales 1.73
  • Price/Cash Flow 13.62
  • Price/Book 1.64
Trade OMCL with:

Options Overview Details

View History
  • Implied Volatility 53.35% ( -0.43%)
  • Historical Volatility 36.76%
  • IV Percentile 34%
  • IV Rank 30.45%
  • IV High 94.83% on 04/16/24
  • IV Low 35.19% on 06/20/24
  • Put/Call Vol Ratio 0.55
  • Today's Volume 17
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 2,751
  • Open Int (30-Day) 2,579

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.19
  • Number of Estimates 3
  • High Estimate 0.24
  • Low Estimate 0.16
  • Prior Year 0.36
  • Growth Rate Est. (year over year) -47.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.96 +6.94%
on 08/21/24
45.84 -2.12%
on 08/29/24
+2.32 (+5.45%)
since 08/16/24
3-Month
25.12 +78.62%
on 07/09/24
45.84 -2.12%
on 08/29/24
+16.96 (+60.77%)
since 06/14/24
52-Week
25.12 +78.62%
on 07/09/24
56.05 -19.95%
on 09/19/23
-10.68 (-19.23%)
since 09/15/23

Most Recent Stories

More News
Omnicell: Q2 Earnings Snapshot

Omnicell: Q2 Earnings Snapshot

OMCL : 44.87 (+3.96%)
Omnicell: Q1 Earnings Snapshot

Omnicell: Q1 Earnings Snapshot

OMCL : 44.87 (+3.96%)
Omnicell: Q4 Earnings Snapshot

Omnicell: Q4 Earnings Snapshot

OMCL : 44.87 (+3.96%)
Omnicell: Q3 Earnings Snapshot

Omnicell: Q3 Earnings Snapshot

OMCL : 44.87 (+3.96%)
Omnicell: Q2 Earnings Snapshot

Omnicell: Q2 Earnings Snapshot

OMCL : 44.87 (+3.96%)
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO

/PRNewswire/ -- EmpiRx Health, the industry's only value-based PBM, today announced that the company's president, Danny Sanchez, has been named Chief Executive...

OMCL : 44.87 (+3.96%)
Omnicell to Present at the BofA Securities 2023 Healthcare Conference

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference...

OMCL : 44.87 (+3.96%)
Omnicell: Q1 Earnings Snapshot

Omnicell: Q1 Earnings Snapshot

OMCL : 44.87 (+3.96%)
Omnicell Announces First Quarter 2023 Results

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results...

OMCL : 44.87 (+3.96%)
Long Island University and Omnicell Launch Center for Innovative Medication Management

Long Island University and Omnicell, Inc. (Nasdaq: OMCL) (Omnicell), a leading provider of medication management and adherence tools for health systems and pharmacies, announced the opening of the Center...

OMCL : 44.87 (+3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 47.59
2nd Resistance Point 46.32
1st Resistance Point 45.60
Last Price 44.87
1st Support Level 43.61
2nd Support Level 42.34
3rd Support Level 41.62

See More

52-Week High 56.05
Last Price 44.87
Fibonacci 61.8% 44.23
Fibonacci 50% 40.58
Fibonacci 38.2% 36.94
52-Week Low 25.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar